| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |